Did a MiniMed insulin pump failure cause you serious harm — and did your clinical team respond the way they should have?
Clinician assesses patient, confirms pump settings, and programmes correct basal and bolus insulin rates
Patient and carers receive training on alarm recognition, site care, and when to seek urgent help
Clinical team monitors blood glucose levels regularly and responds promptly to alarms or abnormal readings
Any pump malfunction, occlusion, or site failure triggers immediate clinical review and glucose correction
Patient maintains stable glucose control with no preventable hypoglycaemic or hyperglycaemic crisis
If a clinician skipped or mishandled any of these steps, and serious harm followed, the failure may meet the legal threshold for medical negligence.
Understanding the MiniMed insulin pump: what normally happens
A MiniMed insulin pump is a small electronic device that delivers insulin continuously through a thin tube inserted under the skin. Medtronic manufactures the MiniMed range. Doctors prescribe these pumps primarily for people with Type 1 diabetes who need precise, around-the-clock insulin delivery.
The pump replaces the need for multiple daily injections. Instead, it delivers a steady background dose called a basal rate, and the patient or clinician can programme extra doses — called boluses — around meals or when blood glucose rises. Some MiniMed models also connect to a continuous glucose monitor (CGM), which tracks blood sugar in real time and can automatically adjust insulin delivery.
Proper care involves more than just fitting the device. A trained clinician must programme the correct settings for each individual patient. Nurses and diabetes educators must teach the patient how to recognise alarms, change infusion sites, and identify signs of pump failure. Regular clinical review must confirm the pump is working as intended. For more general information about diabetes management, Healthdirect Australia provides a useful starting point.
Key fact: MiniMed pumps deliver insulin 24 hours a day. Even a brief interruption or incorrect dose can cause blood glucose to swing dangerously within hours.
Key fact: Medtronic has issued multiple recalls and safety notices for MiniMed pump models in Australia, including warnings about over-delivery of insulin and cybersecurity vulnerabilities.
Key fact: Severe hypoglycaemia — blood sugar that drops too low — can cause permanent brain damage or death if a clinician does not treat it quickly.
Key fact: Diabetic ketoacidosis (DKA) — a dangerous build-up of acids caused by too little insulin — can develop within hours if a pump occlusion goes undetected.
When things start to go wrong
Pump-related harm does not always announce itself dramatically. Sometimes a patient feels unwell and assumes it is a normal part of managing diabetes. Other times, a clinician dismisses a complaint or fails to act on a clear warning sign.
Recognising the difference between an expected fluctuation and a dangerous failure matters enormously. The following warning signs should have prompted immediate clinical action.
Warning signs that should have prompted urgent clinical action:
• Persistent high blood glucose readings despite bolus doses — possible pump occlusion or site failure
• Unexplained low blood glucose — possible over-delivery of insulin due to programming error or device fault
• Pump alarm that a clinician or carer ignored or silenced without investigating
• Nausea, vomiting, or rapid breathing in a pump user — possible early diabetic ketoacidosis
• Loss of consciousness or seizure in a patient wearing a pump — possible severe hypoglycaemia
• Infusion site that appeared red, swollen, or blocked — possible insulin absorption failure
• Patient or carer reporting that the pump felt different, made unusual sounds, or showed error codes
Each of these signs required a clinician to investigate promptly. Waiting, dismissing the concern, or failing to check the device against the patient’s glucose readings created a window in which serious harm could develop.
A common pattern — where care can break down
Harm from MiniMed pump failures rarely happens because of one single mistake. More often, several small failures combine. The Australian Commission on Safety and Quality in Health Care has identified medication safety — including insulin delivery — as a priority area precisely because these failures are both common and preventable.
Incorrect programming at initiation
A clinician programmes the pump with the wrong basal rate or bolus settings. This error may go undetected for days if nobody checks the patient’s glucose logs against the programmed doses. Over time, the patient receives either too much or too little insulin — both of which cause serious harm.
Failure to respond to device alarms
MiniMed pumps generate alarms when something goes wrong — a blocked tube, a low battery, a motor error. In hospital settings, nursing staff sometimes silence alarms without investigating the cause. At home, a carer may not understand what an alarm means. Either way, the underlying problem continues unchecked.
Inadequate patient education
A diabetes educator or nurse fails to teach the patient how to recognise a pump failure, how to check blood glucose manually when the pump alarms, or when to seek urgent help. The patient then misses the signs of a developing crisis because nobody equipped them to recognise those signs.
Delayed response to hypoglycaemia
A patient on a MiniMed pump develops severe hypoglycaemia — blood sugar drops to a dangerous level. Nursing staff or a treating doctor delays administering glucose or glucagon. Every minute of severe hypoglycaemia increases the risk of permanent brain injury.
Failure to act on a known device recall
Medtronic has recalled specific MiniMed models in Australia. A treating clinician who knew about a recall but did not act — by replacing the device, adjusting monitoring, or warning the patient — may have failed in their duty of care.
Inadequate handover between clinical teams
A patient transfers from one ward to another, or from hospital to home, and the receiving team receives no clear information about the pump settings, the patient’s glucose targets, or any recent alarms. The new team then manages the patient without the information they needed to keep them safe.
Occasional blood glucose fluctuations despite correct pump use
Mild site irritation at the infusion point
Pump alarm that a clinician investigates and resolves promptly
Temporary hyperglycaemia during illness, corrected with a bolus dose
Persistent high or low glucose that a clinician does not investigate
Pump alarm silenced without any clinical review
Severe hypoglycaemia or DKA that develops after a known warning sign was ignored
Programming error that a clinician does not detect during a routine review
Why this matters legally
Every clinician who treats a patient owes that patient a duty of care — a legal obligation to provide treatment that meets the standard a competent clinician in the same field would have provided. This duty applies to the doctor who programmes the pump, the nurse who monitors alarms, the diabetes educator who trains the patient, and the hospital that employs them.
Not every bad outcome from a MiniMed pump amounts to negligence. Diabetes is a complex condition. Blood glucose can fluctuate even when a pump works perfectly and a clinician does everything right. The law does not hold clinicians responsible for every complication — only for failures that fall below the standard of reasonable care.
The question a court asks is not “did something go wrong?” but “did the clinician act as a competent clinician in that role would have acted?” If the answer is no, and that failure caused measurable harm, the law may recognise a claim. For a broader explanation of how this works, see Reframe Legal — Medical Negligence.
A patient on a correctly programmed pump experiences a hypoglycaemic episode that a clinician treats promptly and without lasting harm
A clinician programmes the wrong basal rate, the error goes undetected for days, and the patient suffers a hypoglycaemic seizure causing permanent brain damage
This is a general educational framework only. Each case is assessed on its individual facts.
When MiniMed pump mismanagement may amount to medical negligence
The NSW Civil Liability Act 2002 sets out the legal framework for negligence claims in New South Wales — it defines what standard of care the law expects, and what a person must prove to succeed in a claim.
Several specific scenarios involving MiniMed pumps may meet the legal threshold for negligence.
If a clinician programmed the wrong insulin dose and nobody checked the settings against the patient’s glucose readings, and the patient suffered a hypoglycaemic or hyperglycaemic crisis as a result, that programming error may constitute a breach of the standard of care.
If nursing staff silenced a pump alarm without investigating the cause, and the patient subsequently developed diabetic ketoacidosis or severe hypoglycaemia, the failure to respond to the alarm may be the act of negligence that caused the harm.
If a clinician knew about a Medtronic recall affecting the patient’s specific pump model but did not act — by replacing the device, increasing monitoring, or warning the patient — that failure to act on a known safety risk may support a negligence claim.
If a hospital failed to provide adequate handover when transferring a pump-dependent patient between wards or teams, and the receiving team then made a preventable error because they lacked the necessary information, the hospital’s systems failure may be the source of legal liability.
If a diabetes educator failed to train the patient on how to recognise and respond to pump alarms, and the patient later suffered harm because they did not know what to do when the pump failed, that failure in education may form part of a negligence claim.
When harm becomes long-term or permanent
The most serious MiniMed pump failures cause harm that does not resolve. Severe hypoglycaemia — particularly when a clinician delays treatment — can deprive the brain of glucose long enough to cause permanent damage.
Physical consequences
Prolonged hypoglycaemia can cause hypoxic brain injury — a condition where brain cells die from lack of fuel. Survivors may experience memory loss, difficulty concentrating, personality changes, or loss of motor function. Some patients never fully recover their cognitive capacity. Others require ongoing neurological care for the rest of their lives.
Diabetic ketoacidosis, when a clinician fails to detect a pump occlusion in time, can cause organ damage — particularly to the kidneys. Repeated episodes of severe hyperglycaemia accelerate the long-term complications of diabetes, including nerve damage and vision loss.
Psychological consequences
Surviving a hypoglycaemic coma or a near-fatal DKA episode causes significant psychological trauma. Many patients develop anxiety about using insulin pumps at all. Some develop post-traumatic stress disorder. Family members who witnessed the event often carry their own trauma.
Financial consequences
A patient who suffers permanent brain injury from a pump-related hypoglycaemic event may lose the capacity to work entirely. Ongoing care needs — including rehabilitation, home nursing, and specialist review — accumulate over decades. Families often absorb enormous unpaid caring responsibilities that carry their own financial cost.
What compensation can cover in MiniMed pump negligence cases
NSW law allows people harmed by medical negligence to seek compensation for a range of losses. This includes pain and suffering, lost income (past and future), the cost of ongoing medical treatment, and the cost of care provided by family members or paid carers.
| Level of harm | Typical compensation range |
|---|---|
| Moderate injury | $50,000–$150,000 |
| Serious injury | $150,000–$500,000 |
| Severe / life-changing injury | $500,000+ |
Each case is assessed on its own facts. These figures are general ranges only. A case involving permanent brain injury from a delayed hypoglycaemia response will attract very different compensation from a case involving a shorter-term harm that resolved with treatment.
Time limits apply in NSW. Generally, a person has three years from the date they knew — or ought reasonably to have known — that they suffered harm from negligence. Acting promptly preserves your options.
Bringing it together — do the pieces fit?
You may be reading this because something happened to you, or to someone you love, and you are trying to work out whether it should have happened at all. That is a reasonable question to ask.
The legal question is not whether you suffered harm — it is whether the clinical team’s actions fell below the standard a competent team would have met, and whether that failure caused your harm. Understanding Reframe Legal — How Medical Negligence Claims Work in NSW can help you see how those pieces fit together.
You don’t need certainty to understand your position
Most people who have experienced a serious pump-related event feel uncertain. They wonder whether they are misremembering. They worry they are being unfair to a clinician who seemed to care. They feel guilty for even asking the question.
That uncertainty is normal. Legal clarity does not come from certainty — it comes from examining the facts carefully against the standard of care. You do not need to know whether negligence occurred. A lawyer with expertise in medical negligence examines the clinical records, the pump data, and the sequence of events to answer that question.
Consent is also relevant in pump-related cases. If a clinician changed your pump settings, switched your device model, or enrolled you in a trial without explaining the risks and getting your agreement, that may raise a separate legal issue. Reframe Legal — Informed Consent and Medical Negligence explains how consent failures interact with negligence claims.
If you want to understand the regulatory framework that governs the clinicians involved in your care, AHPRA — Australian Health Practitioner Regulation Agency is the body that registers and regulates health practitioners in Australia.
About the lawyer behind this article
Dr Rosemary Listing is an Australian lawyer with a PhD focused on medical negligence. Her academic and legal work examines the gap between the standard of care that patients are owed and the care they actually receive.
Insulin pump cases occupy a particular place in her practice. The harm in these cases often comes not from the device itself, but from the clinical decisions made around it — the programming, the monitoring, the response to alarms, and the quality of patient education. Dr Listing examines each of those decisions against the standard a competent clinician would have met.
In MiniMed pump cases, delay is frequently the central issue. A clinician who acts within minutes of a hypoglycaemic alarm can prevent permanent harm. One who waits — or who silences the alarm without investigating — may allow irreversible injury to occur. That distinction matters enormously in law.
People who approach Dr Listing are not looking to punish anyone. Most want to understand what happened and whether it should have happened. That is the question her work is designed to answer.
Dr Listing’s role is to assess whether the standard of care was met — not to assume it was not. Where the evidence supports a claim, she helps clients understand their legal position clearly and without pressure.
This article is general legal information only. It does not constitute legal advice. Each person’s circumstances are different. The law discussed applies to New South Wales, Australia. Time limits apply to legal claims.